Prime Medicine, Inc. (PRME)
NASDAQ:PRME
Want to see PRME full AI Analyst Report?
Total Valuation
Prime Medicine, Inc. has a market cap or net worth of $511.15M. The enterprise value is $583.23M.
Market Cap$511.15M
Enterprise Value$583.23M
Share Statistics
Prime Medicine, Inc. has 180,617,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding180,617,450
Owned by Insiders46.80%
Owned by Institutions27.60%
Financial Efficiency
Prime Medicine, Inc.’s return on equity (ROE) is -1.66 and return on invested capital (ROIC) is -66.48%.
Return on Equity (ROE)-1.66
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-66.48%
Return on Capital Employed (ROCE)-0.68
Revenue Per Employee21.64K
Profits Per Employee-939.92K
Employee Count214
Asset Turnover0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Prime Medicine, Inc. is ―. Prime Medicine, Inc.’s PEG ratio is 0.14.
PE Ratio―
PS Ratio111.44
PB Ratio4.27
Price to Fair Value4.27
Price to FCF-3.09
Price to Operating Cash Flow-3.34
PEG Ratio0.14
Income Statement
In the last 12 months, Prime Medicine, Inc. had revenue of 4.63M and earned -201.14M in profits. Earnings per share was -1.35.
Revenue4.63M
Gross Profit-2.69M
Operating Income-208.35M
Pretax Income-201.14M
Net Income-201.14M
EBITDA-195.76M
Earnings Per Share (EPS)-1.35
Cash Flow
In the last 12 months, operating cash flow was -156.42M and capital expenditures -2.32M, giving a free cash flow of -158.74M billion.
Operating Cash Flow-156.42M
Free Cash Flow-158.74M
Free Cash Flow per Share-0.88
Dividends & Yields
Prime Medicine, Inc. pays an annual dividend of $0.8, resulting in a dividend yield of ―
Dividend Per Share$0.8
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.79
52-Week Price Change139.84%
50-Day Moving Average3.48
200-Day Moving Average4.00
Relative Strength Index (RSI)33.31
Average Volume (3m)2.13M
Important Dates
Prime Medicine, Inc. upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Prime Medicine, Inc. as a current ratio of 4.84, with Debt / Equity ratio of 149.30%
Current Ratio4.84
Quick Ratio4.84
Debt to Market Cap0.23
Net Debt to EBITDA-0.27
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Prime Medicine, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Prime Medicine, Inc. EV to EBITDA ratio is -2.91, with an EV/FCF ratio of -3.41.
EV to Sales122.97
EV to EBITDA-2.91
EV to Free Cash Flow-3.41
EV to Operating Cash Flow-3.50
Balance Sheet
Prime Medicine, Inc. has $135.50M in cash and marketable securities with $114.51M in debt, giving a net cash position of $20.98M billion.
Cash & Marketable Securities$135.50M
Total Debt$114.51M
Net Cash$20.98M
Net Cash Per Share$0.12
Tangible Book Value Per Share$0.81
Margins
Gross margin is -1082.70%, with operating margin of -4498.06%, and net profit margin of -4342.44%.
Gross Margin-1082.70%
Operating Margin-4498.06%
Pretax Margin-4342.44%
Net Profit Margin-4342.44%
EBITDA Margin-4226.21%
EBIT Margin-4342.44%
Analyst Forecast
The average price target for Prime Medicine, Inc. is $7.80, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.80
Price Target Upside104.72% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast4.89%
EPS Growth Forecast24.20%